Analyst Reco. Novartis AG

Equities

Real-time Estimate Cboe Europe Other stock markets 10:10:23 16/01/2026 GMT			5-day change	1st Jan Change
115.91 ^CHF	+1.25%		+1.37%	+5.47%

01-15	Trump Launches Health Care Plan to Reduce Drug Costs	MT
01-15	Pharma sector doubles down on AI amid hopes of slashing costs, timelines	RE

01-15	NOVARTIS AG : Barclays remains Neutral	ZD
01-14	Swiss stocks - Factors to watch on January 14	RE
01-08	NOVARTIS AG : Berenberg reiterates its Neutral rating	ZD
01-07	NOVARTIS AG : Barclays Upgrades to Neutral	ZD
01-05	NOVARTIS AG : Gets a Buy rating from JP Morgan	ZD
12-23	Morningstar Downgrades Novartis to Sell	MT
12-23	NOVARTIS AG : Receives a Buy rating from JP Morgan	ZD
12-17	Sector Update: Tech Stocks Fall Late Afternoon	MT
12-16	NOVARTIS AG : Gets a Buy rating from Deutsche Bank	ZD
12-08	AlphaValue/Baader Europe Ups Novartis Price Target on 'Strong' Execution, 'Vigorous' Growth	MT
12-08	NOVARTIS AG : Upgraded to Buy by JP Morgan	ZD
12-08	Swiss stocks - Factors to watch on December 8	RE
12-05	Novartis target price raised after upgrades
12-03	Sector Update: Health Care Stocks Higher Late Afternoon	MT
12-03	Novartis Shares Rise After Morgan Stanley Upgrade	MT
12-03	Morgan Stanley Upgrades Novartis to Overweight From Equal Weight, $136 Price Target	MT
12-02	Janux dives as gaps in prostate cancer study data worry investors	RE
11-25	Swiss stocks - Factors to watch on November 25	RE
11-21	AlphaValue/Baader Europe Upgrades Novartis to Add Rating, Raises PT	MT
11-21	NOVARTIS AG : Receives a Buy rating from Deutsche Bank	ZD
11-21	NOVARTIS AG : Gets a Neutral rating from UBS	ZD
11-21	NOVARTIS AG : Barclays reiterates its Sell rating	ZD
11-21	NOVARTIS AG : Bernstein remains its Buy rating	ZD
11-20	NOVARTIS AG : UBS reaffirms its Neutral rating	ZD
11-20	Swiss stocks - Factors to watch on November 20	RE

No results for this search

Novartis target price raised after upgrades

December 05, 2025 at 04:23 pm

Novartis CEO Says They Will Have to 'Tackle Rhetoric' in US Healthcare